We recently published a list of Jim Cramer’s Lightning Rounds: 12 Stocks Under the Spotlight. In this article, we are going ...

Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Merus (MRUS – Research Report) yesterday and set a price target of ...

Merus (NASDAQ:MRUS – Get Free Report) had its price target hoisted by research analysts at Citigroup from $89.00 to $97.00 in ...

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to ...

In a report released today, Asthika Goonewardene from Truist Financial reiterated a Buy rating on Merus (MRUS – Research Report). The company’s ...

Needham & Company LLC reaffirmed their buy rating on shares of Merus (NASDAQ:MRUS – Free Report) in a report published on Monday,Benzinga reports. The firm currently has a $85.00 price target on the ...

Bizengri (zenocutuzumab-zbco) as the first and only treatment indicated for adults with pancreatic adenocarcinoma or ...

In trading on Monday, shares of Merus NV (Symbol: MRUS) entered into oversold territory, hitting an RSI reading of 29.5, after changing hands as low as $44.16 per share. By comparison, the current ...

Merus partners with Partner Therapeutics for U.S. rights to Zeno in NRG1+ cancer. Updated petosemtamab data emerge as a key ...

Team Rebounds: 1. Team Turnovers: 1. Blocked Shots: 6 (Anderson, Gonzalez, Linhardt, Mims, Mrus). Turnovers: 15 (Anderson 2, Linhardt 2, Payne 2, Steele 2, Yearout 2, Brickner, Gonzalez, Klapper, ...

Get real-time COLLEGEBASKETBALL basketball coverage and scores as Idaho Vandals takes on Oregon State Beavers. We bring you the latest game previews, live stats, and recaps on CBSSports.com ...

of roughly $16.5 million. Price Action: MRUS stock is down 3.70% at $43.80 at the last check on Thursday.